Coenzyme Q10 prevents GDP-sensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes

Diabetologia. 2012 May;55(5):1535-43. doi: 10.1007/s00125-012-2469-5. Epub 2012 Feb 5.

Abstract

Aims/hypothesis: Increased oxygen consumption results in kidney tissue hypoxia, which is proposed to contribute to the development of diabetic nephropathy. Oxidative stress causes increased oxygen consumption in type 1 diabetic kidneys, partly mediated by uncoupling protein-2 (UCP-2)-induced mitochondrial uncoupling. The present study investigates the role of UCP-2 and oxidative stress in mitochondrial oxygen consumption and kidney function in db/db mice as a model of type 2 diabetes.

Methods: Mitochondrial oxygen consumption, glomerular filtration rate and proteinuria were investigated in db/db mice and corresponding controls with and without coenzyme Q10 (CoQ10) treatment.

Results: Untreated db/db mice displayed mitochondrial uncoupling, manifested as glutamate-stimulated oxygen consumption (2.7 ± 0.1 vs 0.2 ± 0.1 pmol O(2) s(-1) [mg protein](-1)), glomerular hyperfiltration (502 ± 26 vs 385 ± 3 μl/min), increased proteinuria (21 ± 2 vs 14 ± 1, μg/24 h), mitochondrial fragmentation (fragmentation score 2.4 ± 0.3 vs 0.7 ± 0.1) and size (1.6 ± 0.1 vs 1 ± 0.0 μm) compared with untreated controls. All alterations were prevented or reduced by CoQ10 treatment. Mitochondrial uncoupling was partly inhibited by the UCP inhibitor GDP (-1.1 ± 0.1 pmol O(2) s(-1) [mg protein](-1)). UCP-2 protein levels were similar in untreated control and db/db mice (67 ± 9 vs 67 ± 4 optical density; OD) but were reduced in CoQ10 treated groups (43 ± 2 and 38 ± 7 OD).

Conclusions/interpretation: db/db mice displayed oxidative stress-mediated activation of UCP-2, which resulted in mitochondrial uncoupling and increased oxygen consumption. CoQ10 prevented altered mitochondrial function and morphology, glomerular hyperfiltration and proteinuria in db/db mice, highlighting the role of mitochondria in the pathogenesis of diabetic nephropathy and the benefits of preventing increased oxidative stress.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / physiopathology
  • Disease Models, Animal
  • Glomerular Filtration Rate / drug effects
  • Glomerular Filtration Rate / physiology
  • Guanosine Diphosphate / metabolism
  • Ion Channels / blood
  • Ion Channels / physiology*
  • Kidney Glomerulus / drug effects*
  • Kidney Glomerulus / physiopathology
  • Kidney Glomerulus / ultrastructure
  • Mice
  • Mitochondria / drug effects*
  • Mitochondria / ultrastructure
  • Mitochondrial Proteins / blood
  • Mitochondrial Proteins / physiology*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Oxygen Consumption / drug effects
  • Oxygen Consumption / physiology
  • Proteinuria / drug therapy*
  • Proteinuria / physiopathology
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / therapeutic use
  • Uncoupling Protein 2
  • Vitamins / therapeutic use*

Substances

  • Blood Glucose
  • Ion Channels
  • Mitochondrial Proteins
  • Ucp2 protein, mouse
  • Uncoupling Protein 2
  • Vitamins
  • Ubiquinone
  • Guanosine Diphosphate
  • coenzyme Q10